TCR like antibody targeting NKG2A/HLA-E (Abexxa)

N/A

Report date: 2025/03/20 09:41:25

Base Information

Drug NameTCR like antibody targeting NKG2A/HLA-E (Abexxa)
Drug Alias NameHLA-E checkpoint inhibitor (Abexxa)NKG2A/HLA-E inhibitors (Abexxa)
ClassificationBiologics
Mechanisms of ActionHistocompatibility antigens class I inhibitorsNK cell lectin-like receptor subfamily C member 1 antagonists
TargetsHistocompatibility antigens class INK cell lectin-like receptor subfamily C member 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbexxa Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbexxa Biologics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A